Julia Gregory
Director/Board Member bij BIOHAVEN LTD.
Vermogen: 1 M $ op 31-03-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Chris Cargill | M | 40 | 7 jaar | |
| Gregory Bailey | M | 68 | 10 jaar | |
| Vladimir Coric | M | 53 | 9 jaar | |
| George Clark | M | - | 5 jaar | |
| Irina Antonijevic | M | 59 | 2 jaar | |
| Michael Heffernan | M | 59 | 4 jaar | |
| John Childs | M | 81 | 10 jaar | |
| Robert Hugin | M | 69 | 4 jaar | |
| Arthur Sands | M | 62 | 10 jaar | |
| Kimberly Gentile | F | 56 | 9 jaar | |
| Clifford Bechtold | M | - | 7 jaar | |
| Kishan Mehta | M | 38 | 3 jaar | |
| David Lacey | M | 71 | 8 jaar | |
| Douglas G. Gray | M | - | - | |
| Christine Ring | M | 59 | 5 jaar | |
| Samuel Barker | M | 81 | 24 jaar | |
| Kirk Dornbush | M | - |
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | 21 jaar |
| Amit Chunilal Nathwani | M | 64 |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | 9 jaar |
| Michiel C. McCarty | M | 72 |
M.M. Dillon & Co. LLC
 M.M. Dillon & Co. LLC Investment Banks/BrokersFinance M.M. Dillon & Co. operates as an investment banking firm. It offers capital raising and advisory services across all forms of securities. The firm also provides mergers and acquisition, capital raising, private placement, capital restructuring, public equity offering, and transaction advisory services. It provides services to the healthcare, technology, media & telecom, industrial, energy, clean tech and gaming industries. The company was founded by George W. Bickerstaff III in 2009 and is headquartered in Greenwich, CT.
Dillon, Read & Co., Inc.
| 28 jaar |
| Andrew Hall | M | - | 4 jaar | |
| Matthew Buten | M | 62 | 3 jaar | |
| Jason Daniel Kantor | M | - | 4 jaar | |
| Ray Debbane | M | 69 | 17 jaar | |
| Michael P. Bailey | M | 58 | 4 jaar | |
| Edward Saltzman | M | 69 | 2 jaar | |
| Jennifer Porcelli | F | - | 2 jaar | |
| Saman Maleki | M | - | 2 jaar | |
| Irfan Qureshi | M | - | - | |
| Delphine Davan | F | - | 5 jaar | |
| Paloma Moraleda | F | - | 2 jaar | |
| Megan M. Dow | M | - | 4 jaar | |
| Michael Kalos | M | 62 | 3 jaar | |
| David Saunders | M | - | 4 jaar | |
| David Roblin | M | 57 | 6 jaar | |
| Markus Warmuth | M | 53 | 6 jaar | |
| Philippe Amouyal | M | 65 | 17 jaar | |
| Judith Reinsdorf | F | 60 | 3 jaar | |
| George Bickerstaff | M | 68 |
M.M. Dillon & Co. LLC
M.M. Dillon & Co. LLC Investment Banks/BrokersFinance M.M. Dillon & Co. operates as an investment banking firm. It offers capital raising and advisory services across all forms of securities. The firm also provides mergers and acquisition, capital raising, private placement, capital restructuring, public equity offering, and transaction advisory services. It provides services to the healthcare, technology, media & telecom, industrial, energy, clean tech and gaming industries. The company was founded by George W. Bickerstaff III in 2009 and is headquartered in Greenwich, CT. | 19 jaar |
| Paul Silva | M | 58 | 3 jaar | |
| Robert Lefkowitz | M | 80 | 23 jaar | |
| William Greene | M | - |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | 10 jaar |
| Christopher Sobecki | M | 65 | 17 jaar | |
| Brian Crum | M | 51 | 23 jaar | |
| Gastón Ortega | M | - | 2 jaar | |
| Kuniaki Kaga | M | 72 | 6 jaar | |
| Judith Swain | M | 75 | 17 jaar | |
| Kyle Kuvalanka | M | 56 | 3 jaar | |
| Chris Hollowood | M | 50 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | 9 jaar |
| Noriaki Nagai | M | 66 | 5 jaar | |
| Lori Kunkel | M | 66 | 5 jaar | |
| Shabnam Kazmi | F | - | 1 jaar | |
| Jon Blaskovich | M | - | - | |
| Chris Barrett | M | - | - | |
| Jeffrey Chodakewitz | M | 68 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | - |
| Todd Foley | M | 52 |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | 10 jaar |
| Maryellen McQuade | F | - | - | |
| K. Hirth | M | 72 |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | 9 jaar |
| Jeremy Graff | M | - | 3 jaar | |
| Bruce A. Cohen | M | 71 |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | - |
| Gwenn Hansen | M | 53 | 9 jaar | |
| Shuai Li | M | - | 7 jaar | |
| Colin Love | M | 66 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | - |
| Caroline Dircks | M | - | 4 jaar | |
| Martin Andrews | M | 61 |
Freeline Therapeutics Ltd.
Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | - |
| Melissa Beiner | M | - | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Michael Messinger | M | 49 | 22 jaar | |
| Aron M. Knickerbocker | M | 54 | 10 jaar | |
| Timothy Kutzkey | M | 49 | 10 jaar | |
| Declan Doogan | M | 72 | 14 jaar | |
| Robert Nowinski | M | - | 5 jaar | |
| Steven Gilman | M | 71 | 8 jaar | |
| Roger Pomerantz | M | 67 | 9 jaar | |
| Elyse Stock | M | 66 | 5 jaar | |
| Peter Bains | M | 65 | 8 jaar | |
| Frederic Ors | M | 50 | 6 jaar | |
| Gregg Stephen Sando | M | - |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | 12 jaar |
| Albert Scardino | M | 76 | 10 jaar | |
| Francis Sarena | M | 53 | 11 jaar | |
| Barry Kappel | M | 48 | 6 jaar | |
| David Low | M | 65 | 9 jaar | |
| Robert Repella | M | 65 | 2 jaar | |
| Anthony Price | M | - | 8 jaar | |
| Marc Jasmin | M | - | - | |
| Sheng Da Zan | M | 61 | - | |
| Kenny S. Frazier | M | - | - | |
| John P. Birkelund | M | 94 |
Dillon, Read & Co., Inc.
| 16 jaar |
| Robert Tjian | M | 74 | 4 jaar | |
| James F. Tessmer | M | 64 | 20 jaar | |
| Franklin Berger | M | 74 | 11 jaar | |
| Wayne Pisano | M | 69 | 10 jaar | |
| Alfred A. Smithers | M | - | 4 jaar | |
| Jeffrey Tong | M | 48 | 4 jaar | |
| Eric Aguiar | M | 62 | 4 jaar | |
| Alan Nies | M | 86 | 20 jaar | |
| Alan Main | M | 69 | - | |
| Peder K. Jensen | M | 69 | 10 jaar | |
| David Scheinberg | M | 68 | 6 jaar | |
| Steven Alan Tragash | M | 77 | 3 jaar | |
| Frank Palantoni | M | 66 | 19 jaar | |
| Takuya Fujii | M | 78 | 12 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 46 | 46.00% |
| Canada | 14 | 14.00% |
| Japan | 7 | 7.00% |
| Verenigd Koninkrijk | 6 | 6.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Julia Gregory
- Persoonlijk netwerk
